Biomarkers · Chemical
Adalimumab Drug
- Primary unit
- ug/mL
- LOINC codes
- 74117-3
- Tests that measure Adalimumab Drug
- Quest Diagnostics 2, Labcorp 1
Ranges
Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ
Quest Diagnostics, Adalimumab Level and Anti-Drug Antibody 36296
| Population | Interval |
|---|---|
| Adalimumab Level | See Laboratory Report |
| Adalimumab Ab | <12 AU/mL |
Tests
Check the catalog code, specimen, method and preparation for every test that measures Adalimumab Drug. Select up to five tests to compare them side by side.
Quest Diagnostics 2 tests
Single-analyte tests
Adalimumab Level 36298
Serum · Fasting not stated · Turnaround Set up: Tues; Report available: 2-8 days
Quest Diagnostics catalog pageMethod and collection
- Method
- Chemiluminescent Immunoassay
- Preparation
- Collect immediately before next scheduled dose (trough specimen)
- Collection
- Draw blood in non-separator gel tube (red-top) or separator gel tube (SST). Centrifuge and transfer serum to a labeled plastic transport tube.
- Reference notes
- See Laboratory Report
Panels that include this biomarker
Adalimumab Level and Anti-Drug Antibody 36296
2 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Chemiluminescent Immunoassay
- Preparation
- Dietary supplements containing biotin may interfere in assays and may skew results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation. Collect immediately before next scheduled dose (trough specimen).
- Collection
- Draw blood in non-separator gel tube (red-top) or separator gel tube (SST). Centrifuge and transfer serum to a labeled plastic transport tube.
Labcorp 1 test
Panels that include this biomarker
Adalimumab and Anti-Adalimumab Antibody, Dose ASSURE™ ADL 503890
2 analytes · Serum · Fasting not stated · Turnaround 6 - 10 days
Labcorp catalog pageMethod and collection
- Method
- Electrochemiluminescence immunoassay (ECLIA)
- Collection
- Allow a minimum clotting time of 30 to 60 minutes with serum separation within 2 hours of collection. Send serum in a plastic transport tube. To avoid delays in turnaround time when requesting multiple tests on frozen samples, please submit separate frozen specimens for each test requested.
- Reference notes
- • Adalimumab drug level: − Quantitation limit: <0.6 μg/mL − Results ≥0.6 μg/mL indicate detection of adalimumab. In the presence of antiadalimumab antibody, the adalimumab drug level reflects the antibody-unbound fraction of adalimumab concentration in serum. • Antiadalimumab antibody: − Quantitation limit: <25 ng/mL − Results ≥25 ng/mL indicate detection of adalimumab antibody.
0 of 5 tests selected
Pick one moreSources
1 test: codes, specimens, methods, preparation and reference intervals.
Quest Diagnostics test catalog
2 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 74117-3
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for Adalimumab Drug
Registered studies that measure Adalimumab Drug, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.